SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549



                                    FORM 8-K

                                 CURRENT REPORT



                Pursuant to Section 13 or 15(d) of the Securities
                              Exchange Act of 1934



        Date of Report (Date of earliest event reported): March 12, 2007

                            ProAssurance Corporation
             (Exact name of registrant as specified in its charter)

        Delaware                   001-16533                 63-1261433
(State of Incorporation)      (Commission File No.)     (IRS Employer I.D. No.)


 100 Brookwood Place, Birmingham, Alabama                   35209
 (Address of Principal Executive Office)                  (Zip code)

       Registrant's telephone number, including area code: (205) 877-4400


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)
[ ]  Soliciting material pursuant to Rule 14a-12 under the Securities Act (17
     CFR 240.14a-12)
[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17CFR 240.14d-2(b))
[ ]  Pre-commencement communications pursuant to Rule 13e-(c) under the Exchange
     Act (17CFR 240.13e-(c))




Item 7.01   REGULATION FD DISCLOSURE

On  March  12,  2007  we  issued  a news  release  announcing  the  confidential
settlement,  subject to expected final court approval, of a previously-announced
medical  malpractice  verdict in Tampa.  We currently  believe  there will be no
material adverse effect on first quarter results because of this  settlement.  A
copy of that news release,  containing  important risk factors,  is furnished as
Exhibit 99.1 to this filing.

Item 9.01   FINANCIAL STATEMENTS AND EXHIBITS

99.1  News release, dated March 12, 2007, announcing settlement of a medical
      malpractice verdict, subject to expected final court approval.

We are furnishing  exhibit 99.1 to this Current Report on Form 8-K in accordance
with item 7.01, Regulation FD Disclosure.  The exhibit shall not be deemed to be
"filed" for the  purposes of Section 18 of the  Securities  and  Exchange Act of
1934 (the  "Exchange  Act"),  or  otherwise  subject  to the  liability  of such
section,  nor shall such information be deemed  incorporated by reference in any
filing under the Securities  Act of 1933 or the Exchange Act,  regardless of the
general incorporation  language of such filing, except as shall be expressly set
forth by specific reference in such filing. (d) Exhibits


Date: March 12, 2007



                                                PROASSURANCE CORPORATION







                                                By:  /s/ Frank B. O'Neil
                                                --------------------------------
                                                         Frank B. O'Neil
                                                         Senior Vice-President

                                      -2-